Lv3
230 积分 2024-11-20 加入
The expanded French compassionate programme for elexacaftor-tezacaftor-ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study
2天前
已完结
Detection of Five Rare Cystic Fibrosis Mutations Peculiar to Southern Italy: Implications in Screening for the Disease and Phenotype Characterization for Patients with Homozygote Mutations
6天前
已完结
DHCR7 and Smith-Lemli-Opitz syndrome
9天前
已关闭
The genetic landscape and clinical spectrum of nephronophthisis and related ciliopathies
16天前
已完结
A novel ocular phenotype associated with pathogenic variants in MFSD8 leading to macular dystrophy
17天前
已完结
Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study
19天前
已完结
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha‐mannosidosis
23天前
已完结
婴儿β-酮硫解酶缺乏症1例
1个月前
已关闭
Clinical and Genetic Characterization of CAPN3-Related Limb-Girdle Muscular Dystrophies in an Egyptian Cohort
1个月前
已完结
Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer
3个月前
已采纳
Partially Pyrolyzed Binary Metal–Organic Framework Nanosheets for Efficient Electrochemical Hydrogen Peroxide Synthesis
7个月前
已采纳
Leukemia-associated fusion proteins, dek-can and bcr-abl, represent immunogenic HLA-DR-restricted epitopes recognized by fusion peptide-specific CD4+ T lymphocytes
7个月前
已采纳
Sant M, Allemani C, Tereanu C, et al; HAEMACARE Working Group. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. 2010;116(19):3724–3734
7个月前
已采纳
Achieving a Difference in Involved and Uninvolved Light Chains (dFLC) of Less Than 10mg/L Is the New Goal of Therapy in Systemic AL Amyloidosis: Analysis of 916 Patients Treated Upfront with Bortezomib-Based Therapy
7个月前
已采纳
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA
7个月前
已采纳
Characterization of a Genetically Engineered HUDEP2 Cell Line Harboring a Sickle Cell Disease Mutation As a Potential Research Tool for Preclinical Sickle Cell Disease Drug Discovery
7个月前
已采纳
BET Inhibitors Potentiate Activation of p53 and Killing of AML By MDM2 Inhibitors — a Candidate Combination Therapy
7个月前
已采纳
CD200R1 Distinguishes Uncommitted Precursors from Functionally Mature NK Cells within the Human Tonsil Stage 4A NK Cell Population
7个月前
已采纳
SHP2 Inhibition Enhances JAK2 Inhibitor Therapy in Preclinical Models of Myeloproliferative Neoplasms
7个月前
已采纳
皖公网安备34019202002308
